Essential Land joins Altyon and Delancey for redevelopment of GlaxoSmithKline London site

By 2011-02-22T10:34:00

GSK

Residential developer Essential Land has joined forces with fund manager Altyon and Delancey to draw up plans for a mixed-use redevelopment of part of GlaxoSmithKline’s landholding in Beckenham, south east London.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Try Property Week For Free to finish this article.

Sign up now for the following benefits:

  • Unlimited access to Property Week
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article TRY FOR FREE NOW

Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.

Registered users and subscribers SIGN IN here to continue